Success Metrics

Active Trials
1(33%)

Phase Distribution

Ph phase_4
2
67%
Ph not_applicable
1
33%

Phase Distribution

0

Early Stage

0

Mid Stage

2

Late Stage

Phase Distribution3 total trials
Phase 4Post-market surveillance
2(66.7%)
N/ANon-phased studies
1(33.3%)

Highest Phase Reached

Phase 4

Trial Status & Enrollment

Completion Rate

0.0%

0 of 0 finished

Non-Completion Rate

0.0%

0 ended early

Currently Active

1

trials recruiting

Total Trials

3

all time

Status Distribution
Active(3)

Detailed Status

Not yet recruiting2
Active, not recruiting1

Development Timeline

Analytics

Development Status

Total Trials
3
Active
1
Success Rate
N/A
Most Advanced
Phase 4

Trials by Phase

Phase 42 (66.7%)
N/A1 (33.3%)

Trials by Status

not_yet_recruiting267%
active_not_recruiting133%

Recent Activity

1 active trials
Showing 3 of 3
not_yet_recruitingphase_4

The Effect of Dapagliflozin on Exercise and Cardiac Functional Status of Patients After Fontan Procedure

NCT07482943
not_yet_recruitingphase_4

Comparative Study Between (SGLT-2i) and (DPP-4i) in the Prevention of DIC

NCT07436663
active_not_recruitingnot_applicable

Efficacy and Safety of Dapagliflozin in Children With Proteinuria

NCT07204743

Clinical Trials (3)

Showing 3 of 3 trials
NCT07482943Phase 4

The Effect of Dapagliflozin on Exercise and Cardiac Functional Status of Patients After Fontan Procedure

Not Yet Recruiting
NCT07436663Phase 4

Comparative Study Between (SGLT-2i) and (DPP-4i) in the Prevention of DIC

Not Yet Recruiting
NCT07204743Not Applicable

Efficacy and Safety of Dapagliflozin in Children With Proteinuria

Active Not Recruiting

All 3 trials loaded

Drug Details

Intervention Type
DRUG
Total Trials
3